DNA

Ginkgo Bioworks Holdings Inc

• PR Newswire·18h ago

  Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

• Benzinga·05/18 15:25

  U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness Nationwide

• Seeking Alpha·05/13 14:44

  Ginkgo Bioworks: Another Lost Year

• Simply Wall St·05/13 11:37

  Newsflash: Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Have Been Trimming Their Revenue Forecasts

• TipRanks·05/11 15:50

  Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)

• TipRanks·05/10 00:03

  Ginkgo Bioworks Earnings Call: Cash Rich, Revenue Pinched

• Simply Wall St·05/09 03:47

  Ginkgo Bioworks Holdings (DNA) TTM Net Loss Of US$312.8 Million Reinforces Bearish Narratives

• Seeking Alpha·05/08 16:23

  Ginkgo Bioworks slumps 14% after projecting FY26 cash burn of $125M-$150M

• TipRanks·05/08 04:05

  Ginkgo Bioworks Reaffirmed at Buy as Strategic Refocus, Cost Cuts and New Partnerships Support Unchanged $12 Price Target

• Seeking Alpha·05/08 03:33

  Ginkgo outlines $125M-$150M 2026 cash burn guidance while expanding Nebula to 103 racks

• TipRanks·05/07 20:55

  Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M)

• Dow Jones·05/07 20:47

  *Ginkgo Bioworks Holdings 1Q Basic Loss/Shr $1.39 >DNA

• Dow Jones·05/07 20:45

  *Ginkgo Bioworks Presenting Results of Ops for Former Business Within Discontinued Ops >DNA

• Dow Jones·05/07 20:45

  *Ginkgo Bioworks Previously Reported Fincl Results for Comparable Periods Retrospectively Recast >DNA

• Dow Jones·05/07 20:44

  *Ginkgo Bioworks Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab